Aims: The impact of extracapsular lymph node involvement (LNI) has been studied for several malignancies, including gastrointestinal malignancies. Aim of this study was to assess the current evidence on extracapsular LNI as a prognostic factor for recurrence in gastrointestinal malignancies.
Methods: The Cochrane Database of systematic reviews, the Cochrane central register of controlled trials, and MEDLINE databases were searched using a combination of keywords relating to extracapsular LNI in gastrointestinal malignancies. Primary outcome parameters were incidence of extracapsular LNI and overall five-year survival rates.
Findings: Fourteen manuscripts were included, concerning seven oesophageal, three gastric, one colorectal, and three rectal cancer series with a total of 1528 node positive patients. The pooled incidence of extracapsular LNI was 57% (95% CI: 53-61%) for oesophageal cancer, 41% (95% CI: 36-47%) for gastric cancer, and 35% (95% CI: 31-40%) for rectal cancer. In nine of the 14 studies a multivariate analysis was performed. In eight of these nine studies extracapsular LNI was identified as an independent risk factor for recurrence.
Conclusion: Extracapsular LNI is a common phenomenon in patients with gastrointestinal malignancies. It identifies a subgroup of patients with a significantly worse long-term survival. This systematic review highlights the importance of assessing extracapsular LNI as a valuable prognostic factor. Pathologists and clinicians should be aware of this important feature.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ejso.2006.11.001 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Machine learning and explainable artificial intelligence to predict pathologic stage in men with localized prostate cancer.
Prostate
January 2025
Department of Radiation Oncology, City of Hope National Medical Center, Duarte, California, USA.
Article Synopsis
- Researchers developed machine learning (ML) models to improve the prediction of pathologic stages in prostate cancer patients, aiming to surpass traditional nomograms that utilize available clinical data.
- They trained seven ML models using patient data from the National Cancer Database and found that the extreme gradient boosted trees model provided the best predictions, outperforming existing nomograms in terms of area under the curve (AUC).
- The enhanced accuracy of these ML models can assist oncologists in determining the most suitable treatment options for patients, emphasizing their clinical utility and reliability.
Optimization and validation of 18F-DCFPyL PET radiomics-based machine learning models in intermediate- to high-risk primary prostate cancer.
PLoS One
November 2023
Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Article Synopsis
- The study investigates the use of radiomics from PSMA-PET imaging modeled with machine learning to predict disease risk factors in prostate cancer, focusing on lymph-node involvement (LNI), extracapsular extension (ECE), and postoperative Gleason score (GS).
- A total of 123 intermediate- to high-risk prostate cancer patients were analyzed using various machine learning methods and a comprehensive dataset, leading to significant predictive performance for Gleason score but not for LNI or ECE.
- The results indicate that while ML models show promise, especially for GS prediction, further validation is needed, and combat harmonization techniques can enhance performance in external datasets.
Transperineal template saturation and conventional biopsy for stage prediction in prostate cancer.
BJU Int
December 2023
Department of Urology, University Hospital Zurich, Zurich, Switzerland.
Objective: To evaluate the performance of risk calculators (RCs) predicting lymph node invasion (LNI) and extraprostatic extension (EPE) in men undergoing transperineal magnetic resonance imaging/transrectal ultrasound (TRUS)-fusion template saturation biopsy (TTSB) and conventional systematic TRUS-guided biopsy (SB).
Patients And Methods: The RCs were tested in a consecutive cohort of 645 men undergoing radical prostatectomy with extended pelvic LN dissection between 2005 and 2019. TTSB was performed in 230 (35.
Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters.
Eur Urol Oncol
April 2024
Unit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Laboratory, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.
Background: The role of local therapies including radical prostatectomy (RP) in prostate cancer (PCa) patients with clinical lymphadenopathies on prostate-specific membrane antigen (PSMA) positron emission tomography/computerized tomography (PET/CT) has scarcely been explored. Limited data are available to identify men who would benefit from RP; on the contrary, those more likely to benefit already have systemic disease.
Objective: We aimed to assess the predictors of prostate-specific antigen (PSA) persistence in surgically managed PCa patients with lymphadenopathies on a PSMA PET/CT scan by integrating clinical, magnetic resonance imaging (MRI), and PSMA PET/CT parameters.
Effect of extracapsular lymph node involvement on the prognosis of patients with esophageal squamous cell carcinoma.
Technol Health Care
October 2023
Department of Thoracic Surgery, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Background: According to the eighth edition of the tumor node metastasis (TNM) staging system for esophageal cancer, it is recommended that extracapsular lymph node involvement (EC-LNI) is included as a registered independent variable for the disease. However, its role in the prognosis has not been clearly explained.
Objective: To study the value of EC-LNI in the prognosis of esophageal cancer and attempt to explore its molecular mechanism via an enrichment analysis.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!